untitled
|
|
|
- あゆみ ひろき
- 5 years ago
- Views:
Transcription
1 The traditional diet of Greece and cancer A. P. Simopoulos ( ) Eur. J. Cancer Prev. 13: (2004) 1960 n-6 n-3 ( ) n-3 n-6 2(COX-2) 1(IL-1) IL-6 n-3 n-3 DHA EPA DHA (Simopoulos Childs 1990 Simopoulos 1995a Simopoulos Nestel 1997 Simopoulos 1999a) 1 (1) (2) n-6 n-3 (3) 1
2 (4) (5) (Eaton Konner 1985 Eaton Simopoulos 1989, 1991, 1999a,b,c, 2001 Sanders 2000 Sugano Hirahara 2000 Simopoulos Pavlou 2001a,b) n-6 n (Table Fig. ) (Simopoulos Visioli 2000) ( ) 1930 (Allbaugh 1953) (Allbaugh 1953) (Allbaugh 1953) ( ) (Keys 1970) 1958 Dalmatia (Keys 1970) 1960 n-6 n-3 (Table ) (Simopoulos Robinson 1999) (de Lorgeril 1994, 1998 Renaud 1995 de Lorgeril Salen 2000) Singh (Pella 2003 Singh 1992, 1997, 2002) 2
3 15 n-3 (Simopoulos 1986, 1991 Galli Simopoulos 1989 Galli 1994a,b Salem 1996 Lagarde 1999 Hamazaki Okuyama 2001) n-3 DHA(22:6n-3) n-3 (Simopoulos Robinson 1999) 7 (Keys 1970) ( 37% ) ( 11% ) 30 ( ) E C n-3 PUFA ( ) (Simopoulos 1998) (Lent) n-3 n-6 Renaud (Serge Renaud, INSERM, ) n-3 (Simopoulos Salem 1986 Simopoulos 1992, 1995b) purslane( ) - (18:3n-3 400mg/100g) E(12mg/100g) C(27mg/100g) (15-20mg/100g) (Simopoulos 1992) purslane purslane Purslane 1960 n-3 (Simopoulos Salem 1986) purslane n-3 Ampelistra n-6 n (Simopoulos Salem 1989, 1992) 19.4 n-3 3
4 1960 ( ) n-3 - (Simopoulos 2004) n-6 (Litin Sacks 1993) Sandker Zatphen - (Table )( Sandker 1993) Zatphen n-3 n-3 ( ) - purslane - (18:2n-6) (Table ) (Sandker 1993) Renaud (1986) - (Table ) (n-6 n-3 ) E C de Lorgeril Renaud (de Lorgeril 1994,1998 de Lorgeril Salen 2000 Renaud 1995) - Step 70% - (de Lorgeril 1994) 56 (P=0.03) 61%(P=0.05) de Lorgeril (1998) 4
5 n-3 (de Lorgeril 1994,1998 de Lorgeril Alen 2000 Renaud 1995) ( ) C E - (Slater Block 1991 Hertog 1992 Mazur 1998 Joseph 1999 Weisburger 1999) - EPA(20:5n-3) DHA ( ) DART( )(Burr 1989) (de Lorgeril 1994, 1998 de Lorgeril Salen 2000 Renaud 1995) Singh (Pell 2003 Singh 1992,1997,2002) GISSI (1999) (18:1n-9) n-6 - n-3 n-3 (Simopoulos 1991) n-6 n (Table ) (Birch 1993,1998 Uauy 1994) (Galli Simopoulos 1989 Galli 1994a,b Hamazaki Okuyama 2001 Lagarde 1999 Leaf Weber 1988 Salem 1996 Simopoulos 1991,1997,1999d,2002,2003 Simopoulos Cleland 2003 Simopoulos 1986,1991,1999) (Allbaugh 1953) ( 35%) (7-8%) n-6 n-3 - C E (Simopoulos Salem 1986 Simopoulos 1992,1995b Simopoulos Gopalan 2003 Zeghichi 2003z,b) 5
6 (Slater Block 1991) (Levi 1995) de Lorgeril (de Lorgeril 1994,1998 de Lorgeril Salen 2000 Renaud 1995) (Simopoulos 1999b Simopoulos Visioli 2000)(Fig. ) (de Lorgeril 1998) n-6 n-3 n-6 (20:4n-6) EPA (n-3) (2-4- ) EPA (3-5- ) PUFA n-6 n-3 (Simopoulos 1999d Cowing Saker 2001) ( ) (n-3 EPA DHA ) (Cave 1991 Galli Butrum 1991) n-3 (Karmali 1987) n-6 n-3 2 n-3 (Cowing Saker 2001) 6
7 20 (Nielsen Hansen 1980) Klein (2000) - (Terry 2001) n-3 (De Gomez Dumm Brenner 1975 Hagve Christophersen 1984, 1986 Karmali 1984 Ip 1987 Karmali 1987 Szeluga 1987 Rose Connolly 2000) (Klein 2000) BMI ( n-6 n-3 PUFA ) - - (4 ) 0.36(95% ) - PUFA (Chajes Bougnoux 2003) Germain (1998) PUFA ( ) MDA-MB-231 PUFA DHA 10 7mol/l 54% DHA 21% in vivo DHA n-3 (EPA18% DHA12%) 12g/ 3 0.3kg/ ( ) (Wigmore 1996) Gagos (1998) 60 n-3 PUFA T T 7
8 ( ) n-3 (Gagos 1998) n-3 PUFA 1999 Bougnoux WHO 26 (47%) n-3 PUFA (P<0.004) n-3 PUFA DHA(22:6n-3) (P<0.005) BMI 22:6n-3 (P=0.03) 22:6n-3 Gago-Dominguez (2003) , ( ) Cox n-3 ( n-3 ) 3 (4 ) 26 [ (RR)= % (CI) ] RR ( ) n-6 n-3 n-6 (4 ) (RR= %CI ) RR 2.45 (95%CI P 0.01) n-3 8
9 n-6 n-3 70 n-3 n-6 (Simopoulos ) n-6 n-3 (Eaton Konner 1985 Eaton 1988,1998 Simopoulos 1999b,2002)(Fig.1) n-6 n (Eaton Konner 1985 Eaton 1988,1998 Simopoulos 1999b, 2002,2003) ( ) 1960 n-6 n n-6 n-3 n-3 n-6 (Crawford 1968) (Simopoulos Salem 1989,1992) (van Vliet Katan 1990) (Simopoulos Salem 1986 Simopoulos 1992,1995b) n-3 Table n-6 n-3 (Simopoulos 2003) (Simopoulos Robinson 1999 Simopoulos Visioli 2000) EPA n-3 PUFA n-6 PUFA (Bang 1976 Kromann Green 1980 Nielsen Hansen 1980) EPA Kaizer (1989) Dolecek Grandits (1991) (MRFIT) 18:3 18:2 n-3 (n-6 n-3 ) (Cowing Saker 2001) 9
10 n-6 n-3 (Cowing Saker 2001) (Simopoulos 2001) 2 (Kojima 2001) DeDaterina Habib (2001 )DHA 2 (Calviello 1999 Connolly 1999 Albino 2000 Chen Istfan 2000 Diep 2000 Xi 2000) (Anti 1994) 30 EPA DHA 2 (Fenwick 2003) n-3 (Leng 2003 Pai 2003) Bartram ( ) 2 E2 n-6 n ( ) n-6 n-3 Maillard (2002) n-6 n-3 ( ) n-3 n-3 n-6 n-6 n-3 Ge (2002) Kang (2001) C. elegans n-3 cdna n-6 n-3 Ge n-3 n-6 n-3 n-6 n-3 - EPA n-6 n-3 PUFA 1 1 (Kang 2001) n-3 n-6 n-3 (Ge 2002) 10
11 (200 g/ ) 4.5 (Clark 1996) (Yoshizawa 1998) 90 g/100g 3 4 (Griffin 1982) (3,49,5- ) Polygonum (Arichi 1982) ( B4(LTB4) LTC4) (Kimura 1985 a,b,1995) (Kimura 1995) (Jang 1997 Ciolino 1998 Clement 1998 Fontcave 1998 Ragione 1998 Subbaranmaiah 1998 Sun 1998 Carbo 1999) Lewis DNA (Kimura Okada 2001) PUFA S- (Jones 1989) (Jones 1992) (28.3mg/100g) (27.7mg/100g) 11
12 purslane 18 90% 98 (Block 1985a,b Jones 1992) (Jones 1989 Mannervick 1989) (Wattenberg 1985 Frei 1989) E C - (Bendich 1985 Frei 1988, 1989) DNA (Fuchs 1989 Oleinick 1988) (Buhl 1989 Furukawa 1987) Flagg (1993) ( ) (Renneberg 1982,1987 McCay 1985 Hatzios Bormann 1989) (Koike Patterson 1988 Schupp Renneberg 1988) (De Kok 1981 Earnshaw Johnson 1987 Wise Naylor 1987) purslane mg/100g mg/100g (Simopoulos 1995b) purslane n-6 n-3 ( ) 5 (de Lorgeril 1994) Fig. 12
13 (Greek Column Food Guide) (Simopoulos 1996) Simopoulos Robinson (1999) 1. ( ) n ( ) 6. n-6 7. n-6 n-3 n-3 n-6 n-3 ( :1 ) n-6 n-6 n-3 C E ( ) (1) n-6 n (2) C E - 13
14 n-3 n-6 n-6 n n-6 n-3 EPA ( )n-6 n-6 n-3 (Simopoulos Cleland 2003) EPA DHA MRFIT - n-3 DHA EPA DHA EPA DHA n-6 n-3 n-6 ( ) n-3 ( ) n-6 EPA DHA n-3 14
合併後の交付税について
(1) (2) 1 0.9 0.7 0.5 0.3 0.1 2 3 (1) (a), 4 (b) (a), (c) (a) 0.9 0.7 0.5 0.3 0.1 (b) (d),(e) (f) (g) (h) (a) (i) (g) (h) (j) (i) 5 (2) 6 (3) (A) (B) (A)+(B) n 1,000 1,000 2,000 n+1 970 970 1,940 3.0%
2
5 15.8% 17.1% 13.7% 15 1 34.0%3 1 3 25.7 4 1 76.5 3.3 2 23 3225 36 72.0 13.3 1 26 38 ( 77.8 87.8 69.5 2010 3 20 60 7 20 2 3 1 2 ( 77.8 87.8 69.5 2010 87.9 66.5 3 20 83.030 92.240 93.6 50 91.660 6065 72.9
2002.N.x.h.L.......g9/20
1 2 3 4 5 6 1 2 3 4 5 8 9 1 11 11 12 13 k 14 l 16 m 17 n 18 o 19 k 2 l 2 m 21 n 21 o 22 p 23 q 23 r 24 24 25 26 27 28 k 28 l 29 m 29 3 31 34 42 44 1, 8, 6, 4, 2, 1,2 1, 8 6 4 2 1, 8, 6, 4, 2, 1,2 1, 8
1 2
1 2 4 3 5 6 8 7 9 10 12 11 0120-889-376 r 14 13 16 15 0120-0889-24 17 18 19 0120-8740-16 20 22 21 24 23 26 25 28 27 30 29 32 31 34 33 36 35 38 37 40 39 42 41 44 43 46 45 48 47 50 49 52 51 54 53 56 55 58
3 5 6 7 7 8 9 5 7 9 4 5 6 6 7 8 8 8 9 9 3 3 3 3 8 46 4 49 57 43 65 6 7 7 948 97 974 98 99 993 996 998 999 999 4 749 7 77 44 77 55 3 36 5 5 4 48 7 a s d f g h a s d f g h a s d f g h a s d f g h j 83 83
【知事入れ版】270804_鳥取県人口ビジョン素案
7 6 5 4 3 2 1 65 1564 14 192 193 194 195 196 197 198 199 2 21 22 23 24 1.65 1,4 1.6 1,2 1.55 1, 1.45 6 1.5 8 1.4 4 1.35 1.3 2 27 28 29 21 211 212 213 214 6 5 4 3 2 1 213 218 223 228 233 238 243 248 253
1. 52
51 1. 52 5 2. 1 2 54 4 55 5 1 56 2 57 . 1 1 58 2 1 59 2 4 60 61 62 6 64 4. 65 66 67 5 1 2 4 68 1 69 2 70 1 2 71 72 1 2 7 1 2 74 75 1 76 2 77 1 2 78 4 79 5 80 6. 1 81 2 82 8 84 85 86 87 7. 88 89 8. column
1 2 2 36 8 1212 15 16 20 22 24 26 28 8 14 21 1 31 32 32 3335 37 39 43 45 48 49 5051 54 56 58 6264 6669 43 50 58 2 73 74 7779 8183 85 88 91 93 9698 100 102103 74 85 93 106 106 108 110 112 3 115 116 116
EPSON VP-1200 取扱説明書
4020178-01 w p s 2 p 3 4 5 6 7 8 p s s s p 9 p A B p C 10 D p E 11 F G H H 12 p G I s 13 p s A D p B 14 C D E 15 F s p G 16 A B p 17 18 s p s 19 p 20 21 22 A B 23 A B C 24 A B 25 26 p s p s 27 28 p s p
BAANs理論に基づく保健指導プログラム暫定版
WHO 4 5 10% L- -3 RNA L - 1960-3 RNA mrna Bio Activating Advanced Nutrients BAANs BAANs BAANs BAANs L- (NO) -3 EPA, DHA) RNA RNA DNA TNF- PAI-1 ( ) BAANs 40 50% 20% 1Kg 7,000Kcal 50Kcal 11 50Kcal
EPSON エプソンプリンタ共通 取扱説明書 ネットワーク編
K L N K N N N N N N N N N N N N L A B C N N N A AB B C L D N N N N N L N N N A L B N N A B C N L N N N N L N A B C D N N A L N A L B C D N L N A L N B C N N D E F N K G H N A B C A L N N N N D D
ありがとうございました
- 1 - - 2 - - 3 - - 4 - - 5 - 1 2 AB C A B C - 6 - - 7 - - 8 - 10 1 3 1 10 400 8 9-9 - 2600 1 119 26.44 63 50 15 325.37 131.99 457.36-10 - 5 977 1688 1805 200 7 80-11 - - 12 - - 13 - - 14 - 2-1 - 15 -
EPSON エプソンプリンタ共通 取扱説明書 ネットワーク編
K L N K N N N N N N N N N N N N L A B C N N N A AB B C L D N N N N N L N N N A L B N N A B C N L N N N N L N A B C D N N A L N A L B C D N L N A L N B C N N D E F N K G H N A B C A L N N N N D D
公務員人件費のシミュレーション分析
47 50 (a) (b) (c) (7) 11 10 2018 20 2028 16 17 18 19 20 21 22 20 90.1 9.9 20 87.2 12.8 2018 10 17 6.916.0 7.87.4 40.511.6 23 0.0% 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2.0% 4.0% 6.0% 8.0%
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 A B (A/B) 1 1,185 17,801 6.66% 2 943 26,598 3.55% 3 3,779 112,231 3.37% 4 8,174 246,350 3.32% 5 671 22,775 2.95% 6 2,606 89,705 2.91% 7 738 25,700 2.87% 8 1,134
橡hashik-f.PDF
1 1 1 11 12 13 2 2 21 22 3 3 3 4 4 8 22 10 23 10 11 11 24 12 12 13 25 14 15 16 18 19 20 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 144 142 140 140 29.7 70.0 0.7 22.1 16.4 13.6 9.3 5.0 2.9 0.0
198
197 198 199 200 201 202 A B C D E F G H I J K L 203 204 205 A B 206 A B C D E F 207 208 209 210 211 212 213 214 215 A B 216 217 218 219 220 221 222 223 224 225 226 227 228 229 A B C D 230 231 232 233 A
ネットショップ・オーナー２ ユーザーマニュアル
1 1-1 1-2 1-3 1-4 1 1-5 2 2-1 A C 2-2 A 2 C D E F G H I 2-3 2-4 2 C D E E A 3 3-1 A 3 A A 3 3 3 3-2 3-3 3-4 3 C 4 4-1 A A 4 B B C D C D E F G 4 H I J K L 4-2 4 C D E B D C A C B D 4 E F B E C 4-3 4
1
1 2 3 4 5 (2,433 ) 4,026 2710 243.3 2728 402.6 6 402.6 402.6 243.3 7 8 20.5 11.5 1.51 0.50.5 1.5 9 10 11 12 13 100 99 4 97 14 A AB A 12 14.615/100 1.096/1000 B B 1.096/1000 300 A1.5 B1.25 24 4,182,500
05[ ]戸田(責)村.indd
![05[ ]戸田(責)村.indd](/thumbs/91/106164845.jpg "05[ ]戸田(責)村.indd")
147 2 62 4 3.2.1.16 3.2.1.17 148 63 1 3.2.1.F 3.2.1.H 3.1.1.77 1.5.13 1 3.1.1.05 2 3 4 3.2.1.20 3.2.1.22 3.2.1.24 3.2.1.D 3.2.1.E 3.2.1.18 3.2.1.19 2 149 3.2.1.23 3.2.1.G 3.1.1.77 3.2.1.16 570 565 1 2
/9/ ) 1) 1 2 2) 4) ) ) 2x + y 42x + y + 1) 4) : 6 = x 5) : x 2) x ) x 2 8x + 10 = 0
1. 2018/9/ ) 1) 8 9) 2) 6 14) + 14 ) 1 4 8a 8b) 2 a + b) 4) 2 : 7 = x 8) : x ) x ) + 1 2 ) + 2 6) x + 1)x + ) 15 2. 2018/9/ ) 1) 1 2 2) 4) 2 + 6 5) ) 2x + y 42x + y + 1) 4) : 6 = x 5) : x 2) x 2 15 12
O157 6/23 7/4 6 25 1000 117,050 6 14:00~15:30 1 2 22 22 14:30~15:30 8 12 1 5 20 6 20 10 11 30 9 10 6 1 30 6 6 0 30 6 19 0 3 27 6 20 0 50 1 2 6 4 61 1 6 5 1 2 1 2 6 19 6 4 15 6 1 6 30 6 24 30 59
新たな基礎年金制度の構築に向けて
[ ] 1 1 4 60 1 ( 1 ) 1 1 1 4 1 1 1 1 1 4 1 2 1 1 1 ( ) 2 1 1 1 1 1 1 1996 1 3 4.3(2) 1997 1 65 1 1 2 1/3 ( )2/3 1 1/3 ( ) 1 1 2 3 2 4 6 2.1 1 2 1 ( ) 13 1 1 1 1 2 2 ( ) ( ) 1 ( ) 60 1 1 2.2 (1) (3) ( 9
1 2 3 4 5 6 X Y ABC A ABC B 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 13 18 30 P331 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ( ) 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
26 2 3 4 5 8 9 6 7 2 3 4 5 2 6 7 3 8 9 3 0 4 2 4 3 4 4 5 6 5 7 6 2 2 A B C ABC 8 9 6 3 3 4 4 20 2 6 2 2 3 3 4 4 5 5 22 6 6 7 7 23 6 2 2 3 3 4 4 24 2 2 3 3 4 4 25 6 2 2 3 3 4 4 26 2 2 3 3 27 6 4 4 5 5
mogiJugyo_slide_full.dvi
a 2 + b 2 = c 2 (a, b, c) a 2 a 2 = a a a 1/ 78 2/ 78 3/ 78 4/ 78 180 5/ 78 http://www.kaijo.ed.jp/ 6/ 78 a, b, c ABC C a b B c A C 90 a 2 + b 2 = c 2 7/ 78 C a b a 2 +b 2 = c 2 B c A a 2 a a 2 = a a 8/
P072-076.indd
3 STEP0 STEP1 STEP2 STEP3 STEP4 072 3STEP4 STEP3 STEP2 STEP1 STEP0 073 3 STEP0 STEP1 STEP2 STEP3 STEP4 074 3STEP4 STEP3 STEP2 STEP1 STEP0 075 3 STEP0 STEP1 STEP2 STEP3 STEP4 076 3STEP4 STEP3 STEP2 STEP1
1
1 2 3 4 5 6 7 8 9 0 1 2 6 3 1 2 3 4 5 6 7 8 9 0 5 4 STEP 02 STEP 01 STEP 03 STEP 04 1F 1F 2F 2F 2F 1F 1 2 3 4 5 http://smarthouse-center.org/sdk/ http://smarthouse-center.org/inquiries/ http://sh-center.org/
STEP1 STEP3 STEP2 STEP4 STEP6 STEP5 STEP7 10,000,000 2,060 38 0 0 0 1978 4 1 2015 9 30 15,000,000 2,060 38 0 0 0 197941 2016930 10,000,000 2,060 38 0 0 0 197941 2016930 3 000 000 0 0 0 600 15
1 23G 2 1 2 3 4 5 6 7 3 a a b c a 4 1 18G 18G 6 6 3 30 34 2 23G 48 23G 1 25 45 5 20 145mm 20 26 0.6 1.000 0.7 1.000mm a b c a 20 b c 24 28 a c d 3 60 70 / a RC 5 15 b 1 3 c 0.5 1 4 6 5 a 5 1 b a b a d
L- 19 L L- L-
0131001 15 1 31 49 35 145 14 5 19 4 23 15 3 10 7 15 634 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 L- 19 L- 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49
untitled
1 2 3 4 5 6 7 cm kg 8 9 10 11 12 13 14 15 T A S H A A M.. N.. A.. B.. I 16 17 18 C 19 20 holding 21 22 23 24 STEP1 STEP2 STEP3 STEP4 STEP5 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45
目 次
1 2 3 t 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 IP 169 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67
３．ごみの減量方法.PDF
- 7 - - 8 - - 9 - - 10 - - 11 - - 12 - ( 100 ( 100 - 13-123,550,846 111,195,762 92,663,135 ( 12 25 37 49.2 16 33 49 65.6 15 30 44 59.0 2.5kg) ( 5kg) ( 7.5kg) ( k ( 123,550,846 111,195,762 92,663,135 (
製品案内 価格表 2014/4/1
4 (17) 3 43 5/20370/ 231(504,150) 11 12 10 14-16 10 3 100 17 100kg 5-6 3 13 3 18 18 # # # # #$$ %&$ ' ()* +,-% ' #). +,-%'% / ' # # #$ %&&&'( %)* +'(#$ #$ %&&&'( ++,-). +'(#$ #$ /'( + /0)- +'(#$ %&&&'(
16 41 17 22 12 10
1914 11 1897 99 16 41 17 22 12 10 11 10 18 11 2618 12 22 28 15 1912 13 191516 2,930 1914 5,100 43 1.25 11 14 25 34364511 7.54 191420 434849 72 191536 1739 17 1918 1915 60 1913 70 10 10 10 99.5 1898 19034.17.6
untitled
Cd: cr : 2MG: 2-1MG: 1- RBP: 1.8 2.8 20 5.2 5.2.1 WHO 5.2.1 1 298 g/l 5 g/l Peplow D, Edmonds R. 230mg/kg 2.5mg/kg 246µg/L 161µg/L Lee JS, 2005 5.2.1 11-19 µg/ 0.17-0.30 µg/kg / PTWI 17-30% 0.5µg/ 0.02µg/
取扱説明書 ［F-02F］
F-02F 4. 2 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 a b c d a b c d a b cd 9 e a b c d e 20 2 22 ab a b 23 a b 24 c d e 25 26 o a b c p q r s t u v w d h i j k l e f g d m n a b c d e f g h i j k l m n x 27 o
Table 1 Age Adjusted Mortality in CHD(1985) (rate/ person/year) Fig. 1 The Cause of Death. (K. Uemura, Z. Pisa)
The Forefront of Lipid Nutrition Kazuo KONDO and Tamami IWAMOTO The National Institute of Health and Nutrition (1-23-1, Toyama, Shinjyuku-ku Tokyo, 162) Abstract : The mortality of heart disease in Japan
０４００９０８ｦ医大ニュース８０／医大ニュース第８０号ＰＤＦ
2004 8 80 1 No.80 2004.8 TEL FAX 15 3 24 105 15 5 3 5 14 4 99 67 51 16 16 4 6 100 90 3 15 6 4 7 72 4 5 30 15 15 15 H16.3.24 16 H16.4.6 15 H16.3.5 2 2004 8 80 54 1979 4 25 56 20 1500 10 5cm 1 500 10 50
PSCHG000.PS
a b c a ac bc ab bc a b c a c a b bc a b c a ac bc ab bc a b c a ac bc ab bc a b c a ac bc ab bc de df d d d d df d d d d d d d a a b c a b b a b c a b c b a a a a b a b a
EPSON LP-8900ユーザーズガイド
3 4 5 6 7 8 abc ade w p s 9 10 s s 11 p 12 p 13 14 p s 15 p s A B 16 w 17 C p 18 D E F 19 p w G H 20 A B 21 C s p D 22 E s p w 23 w w s 24 p w s 25 w 26 p p 27 w p s 28 w p 29 w p s 30 p s 31 A s B 32
Step1 Step2 Step3 Step4 Step5 COLUMN.1 Step1 Step2 Step3 Step4 Step5 Step6 Step7 Step8 COLUMN.2 Step1 Step2 Step3 Step4 Step5 COLUMN.3 Step1 Step2 Ste
2 0 1 2 C A L E N D A R 7 8 9 SUN MON TUE WED THU FRI SAT SUN MON TUE WED THU FRI SAT SUN MON TUE WED THU FRI SAT 1 2 3 4 5 6 7 1 2 3 4 8 9 10 11 12 13 14 5 6 7 8 9 10 11 15 16 17 18 19 20 21 12 13 14
arakidonsan.rtf
DHA (ARA) ARA DHA 50 DHA 20 DHA( ) γ 300 mg 170 mg 150 mg 78 mg 57 mg 3,200 mg 2,300 mg 1,700 mg 1,700 mg 1,700 mg β- E FAO DHA( ARA) DHA 2ARA 1 DHA 70mg 100g 35mg 100g 6 6 63 EPA DHA 63 6 EHA DHA 50 WEB
- 2 -
- 1 - - 2 - Table1-3 - - 4-1/2 Table2-5 - 2 3 3 Table2-6 - - 7-3.5 21 28 ( ) ( ) 1887( 20)7 ( ) 1987( 30) 140 YA-1( :125cc) 1954( 29) 8 1955( 30)7 3 1-8 - 20 1980 1980 YH 1-9 - 1-10 - 4 2 2 4 4 3 3 CI
16 23 270 5 1 2 3 1 2 3 1 2 3 6 5 54 44 9 9 4,000 118 7 5 JA 8 1 1 2 16 48,000 1 1 1 1 2 2 3 1, 312. 87 4 5 10 3 31 6 10 4 25 7 3 1 2 8 2 495. 84 1 296. 49 2 199. 35 1 124. 62 54. 50 28. 80 34. 17 54.
C O N T E N T S 3 Introduction 2 3 Introduction 4 5 0 0 20,000 500 1,000 1,500 2,000 2,500 3,000 3,500 40,000 60,000 80,000 100,000 120,000 140,000 kg 105,634 48,220 46,847 21,840 2,690 592 5,765 1,273
- 16 M7.3 14 M6.5 - - - - - A-4 A-5 A-3 F-3 F-1 C-3 G-1,E-6 C-2 D-1 F-2 E-7 J-1 J-3 B-3 K-1 B-3 I-4 I-3 I-2 I-6 C-1 I-5 B-5 B-2 J-2 A-1 A-2 E-1 B-4 I-1 E-2 E-5 B-1,E-4 E-3 A-1 A-2 A-2 A-3 A-4 A-5 A-2
サンプル一覧表.PDF
: 1 30 1 : 1 30 : 8662 60 : 4810 30 1 : 19383 90 : 8872 : 6279 : 7098 180 120 90 : 6405 120 : 7234 :3276 60 280 : 8053 180 : 5512 180 : 4368 100 :4462 120 : 4725 120 : 8851 180 : 3024 180 : 3286 150 :
